The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures
Nucleic Acids Research · 05.01.2024 · 52 (D1) · D545-D551
DOI: 10.1093/nar/gkad1056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 16.11.2023. Verfasst von Brennan Abanades und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, UK. Hauptthemen laut MEDLINE: Antibodies, Databases, Factual. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche, GlaxoSmithKline, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Antibodies are key proteins of the adaptive immune system, and there exists a large body of academic literature and patents dedicated to their study and concomitant conversion into therapeutics, diagnostics, or reagents. These documents often contain extensive functional characterisations of the sets of antibodies they describe. However, leveraging these heterogeneous reports, for example to offer insights into the properties of query antibodies of interest, is currently challenging as there is no central repository through which this wide corpus can be mined by sequence or structure. Here, we present PLAbDab (the Patent and Literature Antibody Database), a self-updating repository containing over 150,000 paired antibody sequences and 3D structural models, of which over 65 000 are unique. We describe the methods used to extract, filter, pair, and model the antibodies in PLAbDab, and showcase how PLAbDab can be searched by sequence, structure, or keyword. PLAbDab uses include annotating query antibodies with potential antigen information from similar entries, analysing structural models of existing antibodies to identify modifications that could improve their properties, and facilitating the compilation of bespoke datasets of antibody sequences/structures that bind to a specific antigen. PLAbDab is freely available via Github (https://github.com/oxpig/PLAbDab) and as a searchable webserver (https://opig.stats.ox.ac.uk/webapps/plabdab/).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oxford Protein Informatics Group, Department of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, UK.
- Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Munich, DE-82377 Penzberg, Germany.
ORCID-Profile: Brennan Abanades, Matthew I J Raybould, Guy Georges, Charlotte M Deane
Förderung
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Engineering and Physical Sciences Research Council
- University of Oxford
Zitieren
APA
Abanades, B., Olsen, T. H., Raybould, M. I. J., Aguilar-Sanjuan, B., Wong, W. K., Georges, G., Bujotzek, A., & Deane, C. M. (2024). The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic Acids Research, 52(D1), D545-D551. https://doi.org/10.1093/nar/gkad1056
Vancouver
Abanades B, Olsen TH, Raybould MIJ, Aguilar-Sanjuan B, Wong WK, Georges G, et al. The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures. Nucleic Acids Research. 2024;52(D1):D545-D551. doi:10.1093/nar/gkad1056
BibTeX
@article{Abanades2024,
author = {Abanades, Brennan and Olsen, Tobias H and Raybould, Matthew I J and Aguilar-Sanjuan, Broncio and Wong, Wing Ki and Georges, Guy and Bujotzek, Alexander and Deane, Charlotte M},
title = {The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {D1},
pages = {D545--D551},
doi = {10.1093/nar/gkad1056}
}
EUVIMED